Research Database

The research database is a compilation of research abstracts and articles about Prader-Willi syndrome (PWS) as well as topics related to PWS. Beginning in November 2007, the database is being reorganized to make its entries more accessible by subject and date, but that process is incomplete, so be sure to try a search (using the search box in the upper right corner above) if you don't find much through the links below.

Entries by date

• 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
• 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990
• 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980
• 1975 | 1970 | 1967

Entries by subject

• PWS-specific articles | PWS-UPD
• Acid/base | Acidosis | Lactate | Lactic acidosis | Lactic acidemia
• Anesthesia | Surgery | Sudden unexpected death | Intercurrent illness | Sepsis | Cytopathic hypoxia
• Behavioral and Psychiatric
  • ADHD | Aggression | Anger | Antisocial behavior | Anxiety | Autism | Behavioral problems | Bipolar disorder | Catatonia | Conduct disorder | Depression | Destructiveness | Egotistic | Hoarding | Impulsivity | Irritability | Lethargy | Lying | Manipulative | Mood lability | OCD | Oppositional defiant disorder, Panic disorder | Perseveration | Psychosis | Rage attacks | Self-harming | Stealing | Stereotypic movement disorder | Stubbornness | Temper tantrums | Violence
  • Neurobehavioral
  • Neurosteroids | Neuroendocrine
    • Stress response
  • Neurotransmitters
    • Acetylcholine | Dopamine | Epinephrine | GABA | Norepinephrine | Serotonin
    • Cholinergic | Dopaminergic | Noradrenergic | Serotonergic
  • Gamma-hydroxybutyrate
• Biochemistry
  • Acetyl groups | Acetyl-CoA | Coenzyme A (CoA)
  • Enzymes | Choline acetyltransferase | Carnitine acetyltransferase | Creatine kinase
  • Organic acids | Methylglutaric acid | Methylglutaconic acid | Hydroxyisovaleric acid | Methylcrotonylglycine acid
  • Fumarate
• Cardiac | Cardiomyopathy | Cor pulmonale
• Central Nervous System (CNS)/Neurological
  • Brain | Brain development | Myelination | Plasticity
  • Amygdala | Cerebellum | Dentate gyrus | Frontal cortex | Hippocampus | Hypothalamus | Stratum radiatum | Striatum | Thalamus
  • Neurological | Neuroendocrine
    • Ataxia | Dexterity, Encephalopathy | Motor skills, Movement disorders | Restless leg syndrome | Seizures | Stroke
  • Blood-brain barrier
• Cognitive | Academic performance | Alertness | Attentiveness | Cognitive impairment | Memory | Planning
• Dermatological
• Developmental
  • Cognitive development
  • Growth | Fetal growth restriction | Failure to thrive
  • Neurodevelopmental
  • Motor development | Fine motor | Gross motor
  • Developmental delays
    • Expressive language | See also Speech
• Drug treatments | Drug safety | Drug efficacy | Drug metabolism
  • Antidepressants
    • SSRIs | Fluoxetine (Prozac) | Fluvoxamine (Luvox) | Femoxetine
    • Tricyclic antidepressants | Desipramine
    • Other antidepressants | Ritanserin | Viloxazine
  • Antipsychotics
  • Bisphosphonates
  • Neuroprotectants | Deprenyl
  • Obesity treatment | Sibutramine
  • Statins
  • Stimulants | Provigil
• Endocrine | Neuroendocrine
  • Growth hormone | Growth hormone physiology | Growth hormone treatment | Growth hormone safety | Growth velocity
    • IGF-1 | IGFBP-1 | IGFBP-3
  • Follicle-stimulating hormone (FSH) | Luteinizing hormone
  • Hormone disruptors
  • Human chorionic gonadotropin
  • Hypogonadism
  • Hypothalamus | HPA axis | Arginine vasopressin | Corticotropin-releasing Hormone | Gonadotropin-releasing Hormone (GNRH, aka luteinising-hormone releasing hormone - LHRH)
  • Pancreas | Glucagon | Insulin | Pancreatic polypeptide
  • Pituitary | Prolactin | Hyperprolactinemia
  • Polycystic ovary syndrome | Amenorrhea | Galactorrhea
  • Sexual development | Premature adrenarche | Premature puberty | Testes
  • Steroid hormones
    • Adrenal | Androgens | Hyperandrogenism | Hypoadrenalism
      • Medulla: Epinephrine/adrenaline | Norepinephrine/noradrenaline
      • Cortex: Aldosterone | Cortisol | DHEA
    • Androstenedione
    • Corticosterone
    • Estrogen | Phytoestrogens
    • Progesterone
    • Testosterone
  • Sex hormone binding globulin
  • Sexual development | Premature adrenarche | Premature pubarche, Precocious puberty | Puberty
  • Thyroid
    • Hyperthyroidism | Hypothyroidism
  • Melatonin
• Genetics
  • PWS genes
    • Primary
      • Imprinted: SNRPN | SNURF
      • Not imprinted: CYFIP1 | NIPA2 | NRF-1 (binding site)
      • Undetermined imprinting: GOLGA8E | WHDC1L1
    • Secondary: CD36-FAT | FMR1 | MECP2 | PPARalpha | PPARbeta | PEPCK
    • Possibles: AMPK | Fatty acid synthase, Foxa2 | GLUT4 | NR4A | PGC-1alpha | PPARgamma | PXR
  • DNA synthesis
  • Gene expression | DNA methylation | Imprinting | Epigenetics | RNA processing | snoRNAs
  • Post-translational modification
    • Acetylation | Glycosylation | Glycoproteins | CDGs | Phosphorylation
• Gastrointestinal
  • Carbohydrate intolerance
  • Celiac disease
  • Digestive malabsorption
  • Food sensitivities
• Hematology
  • Iron | Iron deficiency (w/o anemia) | Iron deficiency anemia | Iron overload | Iron absorption
  • Heme | Heme synthesis | Hemoglobin | Porphyrins
  • Monocytes | Neutrophils | Platelets
  • Mean corpuscular volume (MCV)
  • Thrombocytopenia
• Immunological
  • Allergy
  • Autoimmunity | Inflammatory disease | Lupus
  • Cancer
  • Cytokines | Interleukin-6
  • Immune deficiency | Recurrent infections
  • Sepsis | Cytopathic hypoxia
  • Thymus
  • Vaccination | Vaccine response
• Kidneys | Albumin | BUN | Creatinine | Nephropathy
• Liver | Alanine aminotransferase/ALT | Albumin | Alkaline phosphatase/ALP | Aspartate aminotransferase/AST | Bilirubin | Hepatomegaly | Hyperammonemia | Liver disease
• Metabolism | Homeostasis
  • Energy metabolism
    • Carbohydrate metabolism | Glucose metabolism | Glucose | Glycogen
      • Diabetes | Glucose tolerance | Glycemic index
      • Glycolysis | Gluconeogenesis | Glycogenolysis
      • Lactate | Pyruvate
      • Hypoglycemia | Hyperglycemia
      • Pancreas
        • Glucagon
        • Insulin | Insulin resistance | Hyperinsulinemia | Hypoinsulinemia
    • Fatty acid metabolism | Lipid metabolism | Long-chain fatty acid metabolism
      • Fatty acid oxidation
        • Carnitine | Acetyl-l-carnitine
          • Acylcarnitines
          • Carnitine deficiency
          • Urinary organic acids
      • Free fatty acids
      • Ketosis
    • Dyslipidemia
    • Cholesterol | Hypocholesterolemia
    • Lipolysis | Lipogenesis | Hyperlipogenesis
    • Triglycerides | Glyceroneogenesis
    • Mitochondria | mtDNA depletion
      • Electron transport chain | Complex I | Complex II | Complex III | Complex IV | CoQ10
      • Krebs cycle | Citrate synthase
        • Anaplerotic diet therapy | Anaplerosis | Cataplerosis
          • Pyruvate | Glutamine/glutamate | Propionyl-CoA | Triheptanoin
      • Oxidative phosphorylation | ATP | Mitochondrial uncoupling
      • Oxidative stress | Reactive oxygen species | Glutathione
  • Malnutrition and starvation
  • Protein metabolism | Amino acid oxidation
    • Alanine | Arginine | Glutamate | Glutamine | Glycine | Leucine
  • Inborn errors of metabolism
    • Organic acid metabolism
      • Organic acidurias | Glutaric aciduria | HMG-COA lyase deficiency
      • Organic acidemias | Glutaric acidemia
      • Methylglutaric acid | Methylglutaconic acid | Hydroxyisovaleric acid | Methylcrotonylglycine acid
  • Urea cycle | Ornithine
• Musculoskeletal
  • Activity level | Dexterity | Endurance | Exercise intolerance | Motor skills | Strength
  • Hypotonia | Myopathy | Mitochondrial myopathy | Lipid storage myopathy | Muscle biopsy | Muscle morphology
  • Bone mineral density | Osteoporosis | Bone age | Bone turnover
• Nutrition and diet
  • Low-carb diet | Ketogenic diet | High-protein diet
  • Gluten-free diet | Grains
  • Antinutrients | Lectins | Phytates | Tannins | Trypsin inhibitors
  • Carbohydrates | Fructose
  • Dairy
  • Protein
  • Soy
  • Vegetarian
  • Nutritional supplements
    • Alpha-lipoic acid
    • Antioxidants
    • Calcium
    • Carnitine | Acetyl-l-carnitine
    • Choline
    • CoQ10
    • Creatine
    • Essential fatty acids
    • Inositol
    • Iron | Zinc
    • MCT oil
    • Riboflavin - B2 | Pyridoxine - B6
    • Vitamin C | Vitamin D | Vitamin E
• Obesity
  • Adiponectin | Ghrelin | Leptin
  • Activity level | Exercise | Exercise capacity
  • Appetite | Hyperphagia | Satiety
  • Body composition
  • Eating disorders
  • Obesity treatment | Bariatric surgery | Sibutramine
• Ocular
  • Visual memory
• Oral | Gums | Teeth | Tooth enamel | Tooth mineralization
• Pathways
  • HMG-COA | Cystathionine | Cysteine | Homocysteine | Methionine | Transsulfuration
• Respiratory
  • Hypercapnia | Hypoxia | Hypoventilation
  • Sleep-related breathing disorders | Apnea | Hypopnea | Obstructive sleep apnea
    • Polysomnography
    • Continuous positive airways pressure
• Sleep
  • Cataplexy | Narcolepsy | Hypocretin
  • Excessive daytime sleepiness | Hypersomnolence
  • Polysomnography | Multiple sleep latency test
  • Sleep architecture | Sleep cycling alternating pattern | Sleep disturbances | Sleep onset rapid eye movement
  • Sleep-related breathing disorders (See Respiratory above for complete listing)
• Other PWS-related topics
  • Dysmorphias
  • Hydration
  • Speech | Expressive language | Hearing
  • Thermoregulation | Cold intolerance | Heat intolerance
  • Music therapy
  • Drug metabolism
• Other syndromes
  • Inborn errors of metabolism
  • Ethylmalonic-adipic aciduria
  • Fragile X PWS phenotype
  • Glycogen storage disorders
  • HMG-COA lyase deficiency
  • Lysosomal storage disorders | Alpha-mannosidosis | Mucopolysaccharidosis | Mucopolysaccharidosis Type VII | Beta-glucuronidase
  • Medium-chain acyl-CoA dehydrogenase deficiency
  • Multiple acyl-CoA dehydrogenase deficiency | Glutaric acidemia
  • Organic acidemias
  • Organic acidurias
  • Short-chain acyl-CoA dehydrogenase deficiency,
  • Succinic semialdehyde dehydrogenase deficiency (GABA-related)
  • Coffin-Lowry syndrome
  • Creatine synthesis and transport disorders
  • Leigh syndrome
  • MELAS
  • Rett syndrome
• Miscellaneous issues
  • Environmental health | Mercury | Premature puberty

Old database listing

[ 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 ]
[ 1999 | 1998 | 1997 | 1996 | 1995 | 1994

2006

• 2006-10-01 Bugiani - Effects of riboflavin in children with complex II deficiency
• 2006-09-28 Kwasnicka - Characterization of autism-associated segmental maternal heterodisomy of chromosome 15q11-13 region
• 2006-09-26 Festen - Sleep-related breathing disorders in pre-pubertal children with PWS and effects of GH treatment - Important!!
• 2006-09-21 Moungjaroen - Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung cancer cells
• 2006-09-19 Holmquist - Lipoic acid as novel treatment for Alzheimers and related dementias
• 2006-09-18 Bittel - Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in PWS
• 2006-09-15 Yingzhong - Regulation of body weight by leptin with special reference to hypoxia-induced regulation
• 2006-09-15 Pasek - Role of domain redundancy in genetic robustness against null mutations
• 2006-09-13 Anti-obesity compound found in wakame
• 2006-09-08 Furukawa - Possible relevance of alpha lipoic acid in health supplement in case of insulin autoimmune syndrome
• 2006-09-01 Tanaka - Optimum preparation of levocarnitine chloride solution in the hospital pharmacy
• 2006-09-01 Semenza - Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor-1
• 2006-09-01 Kroonen - Prader-Willi syndrome: clinical concerns for the orthopedic surgeon
• 2006-09-01 Jameel - Alpha-lipoic acid - inhibitor of secretory phospholipase A2 with anti-inflammatory activity
• 2006-09-01 Escames - Pharmacological utility of melatonin in treatment of septic shock
• 2006-09-01 Crill - Relative bioavailability of carnitine supplementation in premature neonates
• 2006-09-01 Batterham - Critical role for peptide YY in protein-mediated satiation and body-weight regulation
• 2006-08-31 Lee - Alpha-lipoic acid suppresses development of collagen-induced arthritis and protects against bone destruction in mice
• 2006-08-30 Wang - Presynaptic mechanisms underlying alpha-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals
• 2006-08-30 Cummings - Ghrelin and short- and long-term regulation of appetite and body weight
• 2006-08-29 Reddy - Behavioral and emotional symptoms of children and adolescents with PWS
• 2006-08-22 Halbower - Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury - Important!!
• 2006-08-15 Schreibelt - Lipoic acid affects cellular migration into the CNS and stabilizes blood-brain barrier integrity
• 2006-08-12 Hultberg - Effect of different antioxidants on glutathione turnover in human cell lines and their interaction with hydrogen peroxide
• 2006-08-10 Cremer - Safety evaluation of alpha-lipoic acid
• 2006-08-07 Cremer - Long-term safety of alpha-lipoic acid consumption - 2-year study
• 2006-08-01 Zou - Case of mosaic supernumerary ring chromosome 15 with two copies of segment 15p11dot1-q14
• 2006-08-01 Nagai - Growth hormone therapy and scoliosis in patients with PWS
• 2006-08-01 Miller - Neurocognitive findings in PWS and early-onset morbid obesity
• 2006-08-01 Kang - Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency
• 2006-08-01 Craig - Growth hormone treatment and adverse events in PWS - data from KIGS
• 2006-08-01 Bough - Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet
• 2006-08-01 Bielarczyk - RS-alpha-lipoic acid protects cholinergic cells against neurotoxicity through restoration of acetyl-CoA level
• 2006-07-15 - Artuch - Cerebellar ataxia with coenzyme Q10 deficiency - diagnosis and follow-up after CoQ10 supplementation
• 2006-07-01 Targonsky - Alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion
• 2006-07-01 Sethumadhavan - L-carnitine and alpha-lipoic acid improve age-associated decline in mitochondrial respiratory chain activity
• 2006-07-01 Oksala - Heat shock protein 60 response to exercise in diabetes - effects of alpha-lipoic acid
• 2006-07-01 Mantadakis - Near demise of child with PWS during elective orchidopexy
• 2006-07-01 Leloup - Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing
• 2006-07-01 Kim - Regional cerebral glucose metabolic abnormality in PWS
• 2006-07-01 Feltrin - Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY GLP-2 and PP secretion
• 2006-07-01 Citak - Serum carnitine levels in children with iron-deficiency anemia with or without pica
• 2006-06-30 Balaji - Uncovering hidden distributed architecture behind scale-free transcriptional regulatory networks
• 2006-06-12 Nagai - GH therapy and scoliosis in PWS
• 2006-06-01 Smith - Dose ranging and efficacy study of high-dose coenzyme Q10 in Huntingtons disease mice
• 2006-06-01 Holsen - Neural mechanisms underlying hyperphagia in PWS
• 2006-06-01 Descheemaeker - Pervasive developmental disorders in PWS
• 2006-05-24 Depeint - Mitochondrial function and toxicity - role of B vitamins on one-carbon transfer pathways
• 2006-05-15 Longo - Disorders of carnitine transport and the carnitine cycle
• 2006-05-09 Hoybye - Inflammatory markers in PWS before and during 12 months GH treatment
• 2006-05-01 Yoshida - Fasting-induced reduction in locomotor activity and reduced response of orexin neurons in carnitine-deficient mice
• 2006-05-01 Sun - Ablation of ghrelin improves diabetic but not obese phenotype of ob-ob mice
• 2006-05-01 Skibska - Protective effects of early administration of alpha-lipoic acid against lipopolysaccharide-induced plasma lipid peroxidation
• 2006-05-01 Johnston - Ketogenic low-carb diets have no metabolic advantage over nonketogenic low-carb diets
• 2006-05-01 Hindmarsh - Use of growth hormone in children
• 2006-05-01 Bonuck - Growth failure and sleep disordered breathing
• 2006-04-15 Mattick - Non-coding RNA
• 2006-04-01 Wilson - Growth hormone and respiratory compromise in PWS
• 2006-04-01 Sundaram - Oxidative stress and DNA single strand breaks in skeletal muscle of aged rats - role of carnitine and lipoic acid
• 2006-04-01 Pocai - Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats
• 2006-04-01 Mulvaney - Behavior problems associated with sleep disordered breathing in school-aged children
• 2006-04-01 Kanaan - Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination - Important!!
• 2006-04-01 Ikematsu - Safety assessment of coenzyme Q10 in healthy subjects
• 2006-04-01 Feng - Regulation of hypothalamus-pituitary-adrenal axis and growth hormone axis in obstructive sleep apnea-hypopnea syndrome patients - Important!!
• 2006-04-01 Clayton - B6-responsive disorders - A model of vitamin dependency
• 2006-03-01 Sybil - Newborn behavior differs with decosahexaenoic acid levels in breast milk
• 2006-01-01 Bezaire - Identification of CD36-FAT on skeletal muscle mitochondrial membranes - essential role in fatty acid oxidation - Important!!
• 2006-02-01 Wainwright - Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate after hypoxia-ischemia
• 2006-02-01 Miller - Short-term effects of GH on sleep abnormalities in PWS - Important!!
• 2006-02-01 Kennedy - Circulating adiponectin levels body composition and obesity-related variables in PWS
• 2006-02-01 Lopez - Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice
• 2006-02-01 Hinton - Neural representations of hunger and satiety in PWS
• 2006-02-01 He - Transcriptional reprogramming and backup between duplicate genes
• 2006-02-01 Aas - Eicosapentaenoic acid increases fatty acid and glucose uptake in cultured human skeletal muscle cells
• 2006-01-24 Horvath - Coenzyme Q10 deficiency and isolated myopathy
• 2006-01-01 Webb - CD36 expression and its relationship with obesity in blood cells from people with and without PWS
• 2006-01-01 Pavone - Adenotonsillectomy for obstructive sleep apnea in children with PWS
• 2006-01-01 Le Roux - Attenuated peptide YY release in obese subjects is associated with reduced satiety
• 2006-01-01 Escames - Melatonin counteracts iNOS-dependent mitochondrial dysfunction in skeletal muscle of septic mice
• 2006-01-01 Carriere - Physiological and physiopathological consequences of mitochondrial reactive oxygen species
• 2006-01-01 Caixas - Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in PWS
• 2006-01-01 Adams - Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements

2005

• 2005-12-01 Seminara - Changes of thyroid function during long-term hGH therapy in GHD children
• 2005-12-01 ODonoghue - Sleep-disordered breathing in PWS and association with neurobehavioral abnormalities
• 2005-12-01 Hoybye - Growth hormone induced lipolysis during short- and long-term administration in adult PWS
• 2005-12-01 Feinle-Bisset - Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid
• 2005-11-01 Littarru - Clinical aspects of coenzyme Q10
• 2005-11-01 Li - Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice
• 2005-11-01 Carrillo-Vico - Beneficial pleiotropic actions of melatonin in experimental mouse model of septic shock
• 2005-10-01 Zhan - NADPH oxidase mediates hypersomnolence and brain oxidative injury in murine model of sleep apnea
• 2005-10-01 Thirunavukkarasu - Lipoic acid improves glucose utilisation and prevents protein glycation and AGE formation
• 2005-10-01 Ince - Characteristics of hyperthermia and its complications in PWS
• 2005-10-01 Crouser - Respiratory failure during critical illness - are mitochondria to blame
• 2005-09-30 Li - Intermittent hypoxia induces hyperlipidemia in lean mice
• 2005-09-01 Uzun - Peripheric and automatic neuropathy in children with type 1 diabetes mellitus - effect of L-carnitine
• 2005-09-01 Callahan - Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis
• 2005-08-22 Rodriguez-Jato - Characterization of cis- and trans-acting elements in imprinted human SNURF-SNRPN locus
• 2005-08-11 Fan - Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia
• 2005-08-01 Suzuki - Discrepancy in polysomnography scoring for patient with obstructive sleep apnea hypopnea
• 2005-08-01 Arnold - Zinc in attention-deficit-hyperactivity disorder
• 2005-08-01 Arnold - Serum zinc correlates with parent- and teacher-rated inattention in children with ADHD
• 2005-07-08 Lee - Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle
• 2005-07-01 Reidl - Death in two female PWS patients during early phase of GH treatment
• 2005-07-01 Nagai - Cause of sudden unexpected death in PWS with or without GH treatment
• 2005-07-01 Kopelevich - Vitamine-like substances L-carnitine and acetyl-L-carnitine
• 2005-06-15 Zhan - Inducible nitric oxide synthase in long-term intermittent hypoxia - hypersomnolence and brain injury
• 2005-06-01 Pline - Effect of creatine intake on renal function
• 2005-06-01 Kato - Acute lymphoblastic leukemia in patient with PWS under growth hormone therapy
• 2005-06-01 Grugni - Death during GH therapy in children with PWS - two new cases
• 2005-06-01 Blaise - Mild neonatal hypoxia exacerbates effects of vitamin-deficient diet on homocysteine metabolism in rats
• 2005-05-01 Tabolacci - Differential epigenetic modifications in FMR1 gene of fragile X syndrome after reactivating pharmacological treatments
• 2005-05-01 Stefan - Nonimprinted PWS-region gene regulates different chromosomal domain in trans
• 2005-05-01 Groeneveld - Few adverse effects of long-term creatine supplementation in placebo-controlled trial
• 2005-05-01 Goldstone - Fasting and postprandial hyperghrelinemia in PWS partially explained by hypoinsulinemia and not due to peptide YY3-36 deficiency
• 2005-04-01 Talebizadeh - Ghrelin peptide YY and their receptors - gene expression in brain from subjects with and without PWS
• 2005-04-01 Somayajulu - Role of mitochondria in neuronal cell death induced by oxidative stress - neuroprotection by Coenzyme Q10
• 2005-03-15 McDonald - Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice
• 2005-03-01 Talebizadeh - Insulin resistance and obesity-related factors in PWS
• 2005-03-01 Maestri - Pilot study on effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy
• 2005-03-01 Lee - Essential role for PWS protein necdin in axonal outgrowth
• 2005-03-01 Itomura - The effect of fish oil on physical aggression in schoolchildren
• 2005-02-15 Calabrese - Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress
• 2005-02-01 Wagner - Distributed robustness versus redundancy as causes of mutational robustness
• 2005-02-01 Lalani - Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency
• 2005-01-01 Singh - Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy
• 2005-01-01 Sacco - Sudden death in PWS during growth hormone therapy
• 2005-01-01 Roepstorff - Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise
• 2005-01-01 Perkins - Expanding the central dogma - regulatory role of nonprotein coding genes and implications for genetic liability to schizophrenia
• 2005-01-01 Mancini - Coenzyme Q10 evaluation in pituitary-adrenal axis disease
• 2005-01-01 Leon - Melatonin mitigates mitochondrial malfunction
• 2005-01-01 Eiholzer - Deaths in children with PWS - a contribution to the debate about the safety of GH treatment
• 2005-01-01 Eder - Free and total carnitine concentrations in pig plasma after oral ingestion of various L-carnitine compounds

2004

• 2004-12-01 Zeisel - Nutritional importance of choline for brain development
• 2004-12-01 Rosen - Increased behavioral morbidity in school-aged children with sleep-disordered breathing
• 2004-11-01 Stanley - Carnitine deficiency disorders in children
• 2004-11-01 Rebouche - Kinetics pharmacokinetics and regulation of L-carnitine and acetyl-L-carnitine metabolism
• 2004-11-01 Liu - Comparison of effects of L-carnitine and acetyl-L-carnitine on carnitine levels, ambulatory activity and oxidative stress in brain of old rats
• 2004-11-01 Adriani - Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats
• 2004-10-18 Kumar - Carnitine supplementation for preterm infants with recurrent apnea
• 2004-10-15 Wu - Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting iNOS expression
• 2004-10-01 Virmani - Role of carnitine esters in brain neuropathology
• 2004-10-01 Rubio-Gozalbo - Carnitine-acylcarnitine translocase deficiency - clinical biochemical and genetic aspects
• 2004-10-01 Litjens - Pharmacokinetics of oral fumarates in healthy subjects
• 2004-10-01 Korotchkina - R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase
• 2004-10-01 Hoybye - Serum adiponectin levels in PWS are independent of anthropometrical parameters and do not change with GH treatment
• 2004-10-01 Gottlieb - Sleep-disordered breathing symptoms associated with poorer cognitive function in 5-year-old children
• 2004-10-01 Civardi - Corticospinal physiology in patients with PWS
• 2004-10-01 Cavun - CDP-choline increases plasma ACTH and potentiates stimulated release of GH, TSH and LH - cholinergic involvement
• 2004-09-01 Melendres - Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing
• 2004-09-01 Huang - Sleep disorders in Taiwanese children with attention deficit-hyperactivity disorder
• 2004-09-01 Hoffman - Maturation of visual acuity is accelerated in breast-fed term infants fed DHA-enriched egg yolk
• 2004-09-01 Butler - Plasma peptide YY and ghrelin levels in infants and children with PWS
• 2004-09-01 Bourre - Role of nutritional factors on structure and function of the brain
• 2004-08-27 Campbell - Novel function for fatty acid translocase -CD36 - involvement in long chain fatty acid transfer into mitochondria
• 2004-08-01 Zhang - Serum adiponectin levels in obstructive sleep apnea-hypopnea syndrome
• 2004-08-01 Ristow - Neurodegenerative disorders associated with diabetes mellitus
• 2004-07-23 Hart - Acetyl-l-carnitine - pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy
• 2004-07-02 Leon - Melatonin and mitochondrial function
• 2004-06-01 Michiels - Physiological and pathological responses to hypoxia
• 2004-06-01 Crespo - Chronic treatment with precursor of cellular phosphatidylcholine ameliorates morphological and behavioral effects of aging in mouse hippocampus
• 2004-05-01 Smith - Lipoic acid as potential therapy for chronic diseases associated with oxidative stress
• 2004-05-01 Lucignani - GABA A receptor abnormalities in PWS
• 2004-04-01 Marriage - Cofactor treatment improves ATP synthetic capacity in oxidative phosphorylation disorders
• 2004-03-15 Veasey - Long-term intermittent hypoxia in mice - protracted hypersomnolence with oxidative injury to sleep-wake brain regions
• 2004-03-15 Samaco - Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders
• 2004-03-01 Yigit - Diabetic ketoacidosis secondary to GH treatment in boy with PWS and steatohepatitis
• 2004-03-01 Vermeulen - Exploratory open label randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome
• 2004-03-01 Veech - Therapeutic implications of ketone bodies - redox states insulin resistance and mitochondrial metabolism
• 2004-03-01 Conant - Therapeutic applications of citicoline for stroke and cognitive dysfunction
• 2004-03-01 Ceddia - Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production
• 2004-03-01 Bizzarri - Maintenance of normal meal-induced decrease in plasma ghrelin levels in children with PWS
• 2004-02-01 Hoybye - Endocrine and metabolic aspects of adult PWS with special emphasis on effects of GH treatment
• 2004-01-01 Xu - Increased oxidative stress associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in mouse model of sleep apnea
• 2004-01-15 Stevenson - Unexpected death and critical illness in PWS
• 2004-01-01 Yoshizumi - Effects of creatine supplementation on renal function
• 2004-01-01 Van Vliet - Sudden death in growth hormone-treated children with PWS
• 2004-01-01 Tauber - Hyperghrelinemia is common feature of PWS and pituitary stalk interruption
• 2004-01-01 Schrander-Stumpel - PWS causes of death in international series of 27 cases
• 2004-01-01 Park - Role of IGF-1 monitoring in GH-treated children
• 2004-01-01 Kalina-Faska - Effects of recombinant growth hormone therapy on thyroid hormone concentrations
• 2004-01-01 Hoybye - Somatropin therapy in adults with PWS
• 2004-01-01 Clark-Taylor - Is autism a disorder of fatty acid metabolism - possible dysfunction of mitochondrial beta-oxidation
• 2004-01-01 Bilici - Double-blind placebo-controlled study of zinc sulfate in treatment of ADHD
• 2004-01-01 Archbold - Cognitive executive dysfunction in children with mild sleep-disordered breathing

2003

• 2003-12-01 Luboshitzky - Pituitary-gonadal function in men with obstructive sleep apnea - effect of CPAP
• 2003-12-01 Hoybye - Peptides associated with hyperphagia in adults with PWS before and during GH treatment
• 2003-12-01 Giavoli - Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency - hypothyroidism
• 2003-11-01 Wainwright - L-carnitine reduces brain injury after hypoxia-ischemia in newborn rats
• 2003-11-01 Inano - Acetyl-L-carnitine permeability across the blood-brain barrier
• 2003-11-01 Durand - Psychiatric manifestations of vitamin B12 deficiency
• 2003-10-15 Horsthemke - Somatic mosaicism for maternal uniparental disomy 15 in a girl with PWS
• 2003-10-01 Stevens - EFA supplementation in children with inattention hyperactivity and other disruptive behaviors
• 2003-10-01 Mattick - Challenging the dogma - hidden layer of non-protein-coding RNAs
• 2003-10-01 Hoybye - Growth hormone-insulin-like growth factor axis in adults with PWS
• 2003-10-01 Gottlieb - Symptoms of sleep-disordered breathing in 5-year-old children are associated with sleepiness and problem behaviors
• 2003-09-04 Batterham - Inhibition of food intake in obese subjects by peptide YY3-36
• 2003-09-01 Bekx - Decreased energy expenditure is caused by abnormal body composition in infants with PWS
• 2003-08-01 Marriage - Nutritional cofactor treatment in mitochondrial disorders - Important!!
• 2003-07-15 Shigematsu - Selective screening for fatty acid oxidation disorders by tandem mass spectrometry - difficulties in practical discrimination
• 2003-07-01 Wu - Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice
• 2003-06-30 Lyoo - Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following creatine supplementation
• 2003-06-01 Yue - Case-control study on psychological symptoms in sleep apnea-hypopnea syndrome
• 2003-06-01 Pascale - Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine
• 2003-06-01 Obici - Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production
• 2003-06-01 Dedeoglu - Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntingtons disease mice
• 2003-06-01 Butler - Coenzyme Q10 levels in PWS
• 2003-06-01 Batterham - Gut hormone peptide YY regulates appetite
• 2003-05-01 Haqq - Effects of GH on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in PWS
• 2003-04-08 Lamperti - Cerebellar ataxia and coenzyme Q10 deficiency
• 2003-04-04 Friedrich - Functional characterization of OCTN2 transporter
• 2003-04-01 Bramnert - GH therapy induces insulin resistance by activating the glucose-fatty acid cycle
• 2003-04-01 Wassmer - Dual pathology in two hypotonic children with PWS and muscle mitochondrial Complex I deficiency - Important!!
• 2003-03-01 OBrien - Sleep and neurobehavioral characteristics of 5-7-year-old children with attention-deficit-hyperactivity disorder
• 2003-02-01 Cameron-Smith - Short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle
• 2003-01-02 Gu - Role of duplicate genes in genetic robustness against null mutations
• 2003-01-01 Wilcken - Introduction to nutritional treatment in inborn errors of metabolism
• 2003-01-01 Malouf - Effect of vitamin B6 on cognition
• 2003-01-01 Haqq - Serum ghrelin levels inversely correlated with body mass index, age, and insulin concentrations in normal children and markedly increased in PWS
• 2003-01-01 Colin - Lipids, depression and suicide
• 2003-01-01 Acuna-Castroviejo - Mitochondrial regulation by melatonin and its metabolites

2002

• 2002-12-01 Tein - Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy
• 2002-12-01 Fink - Bench-to-bedside review - cytopathic hypoxia - Important!!
• 2002-11-08 Grosfeld - Hypoxia-inducible factor-1 transactivates the human leptin gene promoter
• 2002-10-01 Shults - Effects of coenzyme Q10 in early Parkinson disease
• 2002-10-01 Kazal - Prevention of iron deficiency in infants and toddlers
• 2002-09-13 Ambrosini - Transcriptional activation of the human leptin gene in response to hypoxia - involvement of hypoxia-inducible factor-1
• 2002-09-06 Bigini - Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons
• 2002-09-01 Nixon - Sleep and breathing in PWS
• 2002-08-08 Batterham - Gut hormone PYY(3-36) physiologically inhibits food intake
• 2002-08-01 Nordmann - Sudden death of infant with PWS - not unique case
• 2002-08-01 Kramer - Breastfeeding and infant growth - biology or bias
• 2002-07-01 Van Oudheusden - Efficacy of carnitine in treatment of children with attention-deficit hyperactivity disorder
• 2002-07-01 Luboshitzky - Decreased pituitary-gonadal secretion in men with obstructive sleep apnea
• 2002-06-01 Makrides - Nutritional effect of including egg yolk in weaning diet of breast-fed and formula-fed infants - randomized controlled trial
• 2002-05-08 Mortensen - Association between duration of breastfeeding and adult intelligence
• 2002-05-01 Zuckerkandl - Why so many noncoding nucleotides - Eukaryote genome as epigenetic machine
• 2002-05-01 Porretti - rhGH therapy and thyroid function in large group of adult GH-deficient patients - when does L-T(4) therapy become mandatory
• 2002-05-01 Defloor - Articulation in PWS
• 2002-04-01 Nieminen - Growth and biochemical markers of growth in children with snoring and obstructive sleep apnea
• 2002-04-01 Iossa - Acetyl-L-carnitine differently influences nutrient partitioning, serum leptin concentration and skeletal muscle mitochondrial respiration
• 2002-03-01 Goldstone - Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue in women with PWS
• 2002-03-01 Chervin - Inattention, hyperactivity and symptoms of sleep-disordered breathing
• 2002-02-19 Liu - Memory loss in old rats associated with brain mitochondrial decay and RNA-DNA oxidation - partial reversal by acetyl-L-carnitine and-or R-alpha-lipoic acid
• 2002-02-19 Hagen - Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress
• 2002-02-05 Krakauer - Redundancy, antiredundancy and robustness of genomes
• 2002-01-01 L-Allemand - Increased adrenal androgen levels in PWS are associated with insulin, IGF-I and leptin, but not with measures of obesity
• 2002-01-01 Kramer - Optimal duration of exclusive breastfeeding
• 2002-01-01 Eiholzer - Fatal outcome of sleep apnoea in PWS during initial phase of growth hormone treatment - case report

2001

• 2001-12-01 Kido - Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across blood-brain barrier
• 2001-12-01 Hardin - Myocardial metabolism of exogenous FDP consistent with transport by dicarboxylate transporter
• 2001-12-01 Cemeroglu - Low serum carnitine concentrations in healthy children with iron deficiency anemia
• 2001-10-15 Ando - Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats
• 2001-10-01 Packer - Molecular aspects of lipoic acid in prevention of diabetes complications
• 2001-10-01 Calvani - L-acetylcarnitine treatment on fragile X patients hyperactive behaviour
• 2001-08-01 Cacic - Cytochrome c oxidase partial deficiency-associated Leigh disease presenting as extrapyramidal syndrome
• 2001-07-01 Young - Syndromes with salivary dysfunction predispose to tooth wear, including PWS
• 2001-06-01 Defloor - Aerodynamic and acoustic characteristics of voice in PWS
• 2001-05-01 Pineda - Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate
• 2001-05-01 Parr - New technique to elevate night time growth hormone release and potential growth hormone feedback control loop
• 2001-05-01 Manni - Hypersomnia in PWS - clinical-electrophysiological features and underlying factors
• 2001-03-01 Szarfarc - Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate for iron deficiency in pregnant women
• 2001-03-01 Benzi - Creatine as nutritional supplementation and medicinal product
• 2001-02-01 Dewey - Effects of exclusive breastfeeding for four versus six months on maternal nutritional status and infant motor development
• 2001-01-01 Maresova - Carnitine pretreatment can partially change the excitability of the immature nervous tissue
• 2001-01-01 Doshi - PWS with sleep disordered breathing - effect of two years nocturnal CPAP

2000

• 2000-11-06 Butler - Plasma cholecystokinin levels in PWS and obese subjects
• 2000-11-01 Pettegrew - Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties
• 2000-11-01 Chavez - Expression of hypoxia-inducible factor-1alpha in brain of rats during chronic hypoxia
• 2000-10-01 Zeisel - Choline needed for normal development of memory
• 2000-09-01 Poortman - Adverse effects of creatine supplementation - fact or fiction
• 2000-09-01 Carrel - Effects of growth hormone on adipose tissue
• 2000-08-01 Portes - Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone therapy in GH deficient children
• 2000-08-01 Narui - Endocrine disturbances in sleep apnea syndrome
• 2000-08-01 Evans - Alpha-lipoic acid - multifunctional antioxidant improves insulin sensitivity in type 2 diabetes
• 2000-07-29 Rotig - Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency
• 2000-07-01 Myers - Sustained benefit after 2 years of GH on body composition, fat utilization, physical strength and agility, and growth in PWS
• 2000-07-01 Heck - Potential interactions between alternative therapies and warfarin
• 2000-07-01 Arnold - Does zinc moderate essential fatty acid and amphetamine treatment of ADHD
• 2000-06-01 Hiroe - Relationship between hypersomnia and respiratory disorder during sleep in PWS
• 2000-06-01 Green - Effect of metabolic acidosis on the growth hormone-IGF-I endocrine axis
• 2000-04-01 van Mil - Activity related energy expenditure in children and adolescents with PWS
• 2000-04-01 Calvani - Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions - Important!!
• 2000-04-01 Bueno - Serum leptin concentrations in children with PWS and non-syndromal obesity
• 2000-03-01 Birch - Randomized controlled trial of early dietary long-chain polyunsaturated fatty acids and mental development in term infants
• 2000-03-01 American College of Sports Medicine roundtable - physiological and health effects of oral creatine supplementation
• 2000-01-01 Myers - Leptin concentrations in PWS before and after growth hormone replacement
• 2000-01-01 Ide - Effect of dietary alpha-linolenic acid on activity and gene expression of hepatic fatty acid oxidation enzymes
• 2000-01-01 Hamazaki - Anti-stress effects of DHA

1999

• 1999-12-01 Zipf - Glucose homeostasis in PWS and potential implications of growth hormone therapy
• 1999-12-01 Lindgren - Five years of growth hormone treatment in children with PWS
• 1999-11-01 Menendez - Abnormal ventilatory responses in patients with PWS
• 1999-11-01 Lindgren - GH treatment increases CO2 response, ventilation and central inspiratory drive in PWS
• 1999-11-01 Graham - Creatine - review of efficacy and safety
• 1999-10-01 Sawazaki - Effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress
• 1999-10-01 Richdale - Sleep and behaviour disturbance in PWS - questionnaire study
• 1999-06-01 Kidd - Review of nutrients and botanicals in integrative management of cognitive dysfunction
• 1999-06-01 Lass - Effects of coenzyme Q10 and alpha-tocopherol administration on tissue levels
• 1999-04-01 Pinard - Leigh syndrome and leukodystrophy due to partial succinate dehydrogenase deficiency - regression with riboflavin
• 1999-04-01 Mikami - Frequent breathing-related electroencephalogram arousals in mild obstructive sleep apnea
• 1999-04-01 Khamaisi - Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats
• 1999-03-01 Ellaway - Rett syndrome - randomized controlled trial of L-carnitine
• 1999-02-01 Hagen - R-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate
• 1999-01-01 Lindgren - GH treatment of children with PWS - effects on glucose and insulin homeostasis
• 1999-01-01 Hamazaki - Docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress
• 1999-01-01 Bratel - Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea - effects of CPAP

1998

• 1998-12-15 Akefeldt - Cerebrospinal fluid monoamines in PWS
• 1998-12-07 Ment - Association of chronic sublethal hypoxia with ventriculomegaly in developing rat brain
• 1998-12-01 Esnault-Lavandier - Effects of clomipramine on diurnal sleepiness and respiratory parameters in case of PWS
• 1998-11-01 Hudgins - Phenotypic differerencss in African Americans with PWS
• 1998-10-01 Wyatt - Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients
• 1998-10-01 Willatts - Influence of long-chain polyunsaturated fatty acids on infant cognitive function
• 1998-10-01 Kelly - L-Carnitine - therapeutic applications of a conditionally-essential amino acid
• 1998-09-01 Zelzer - Insulin induces transcription of target genes through hypoxia-inducible factor HIF-1alpha-ARNT
• 1998-09-01 Akefeldt - Monoamine oxidase activity elevated in PWS
• 1998-08-29 Willatts - Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age
• 1998-07-01 Guerrero-Ontiveros - Creatine supplementation - effects of chronic creatine ingestion - down-regulation of creatine transporter isoforms in skeletal muscle
• 1998-07-01 Grosso - Growth hormone secretion in PWS
• 1998-07-01 Chiba - Influence of sleep breathing disorder on growth hormone secretion in children with tonsil hypertrophy
• 1998-06-15 Naegele - Cognitive executive dysfunction in patients with obstructive sleep apnea syndrome after CPAP treatment
• 1998-06-01 Brandt - Impaired peripheral somatosensory function in children with PWS
• 1998-05-01 Smith - Treatment of ventilatory failure in PWS
• 1998-04-15 Hart - Salivary abnormalities in PWS
• 1998-04-01 Taivassalo - Effects of aerobic training in mitochondrial myopathies
• 1998-04-01 Butler - Photoanthropometric study of craniofacial traits in individuals with PWS on short-term growth hormone therapy
• 1998-04-01 Bustamante - Alpha-lipoic acid in liver metabolism and disease
• 1998-03-01 Chanoine - Decreased growth hormone response to glucagon in infants after apnea of infancy
• 1998-02-01 Lozoff - Behavior of infants with iron-deficiency anemia
• 1998-02-01 Huang - Vitamin B-6 requirement and status assessment of young women fed a high-protein diet with various levels of B-6
• 1998-01-06 Butler - Comparison of leptin protein levels in PWS and control individuals
• 1998-01-01 Thacker - Growth failure in PWS is secondary to growth hormone deficiency
• 1998-01-01 Hashimoto - Proton magnetic resonance spectroscopy of the brain in patients with PWS

1997

• 1997-11-01 Greene - Consequences of sleep-disordered breathing in childhood
• 1997-08-01 Torel - Serum free carnitine levels in children with recurrent pulmonary infections
• 1997-03-01 Keskin - Could L-carnitine be an acute energy inducer in catabolic conditions
• 1997-02-28 Dell-Anna - Effect of acetyl-L-carnitine on hyperactivity and spatial memory deficits of rats exposed to neonatal anoxia
• 1997-02-13 Kuratsune - High uptake of acetyl-L-carnitine into the brain
• 1997-01-01 Schluter - Respiratory control in children with PWS
• 1997-01-01 Ogle - Mitochondrial myopathy with tRNA-Leu-UUR mutation and complex I deficiency responsive to riboflavin
• 1997-01-01 Ladny - Effect of some drugs on levels of selected cytokines in experimental septic shock
• 1997-01-01 Capecchi - Carnitines increase plasma levels of adenosine and ATP in humans
• 1997-01-01 Brungger - Effect of chronic metabolic acidosis on the growth hormone-IGF-1 endocrine axis

1996

• 1996-12-01 Schuster - Characterization of alterations in glucose and insulin metabolism in PWS
• 1996-12-01 Harris - Is excessive daytime sleepiness characteristic of Prader-Willi syndrome - effects of weight change
• 1996-07-16 Folkers - Relevance of biosynthesis of coenzyme Q10 and four DNA bases for molecular causes and therapy of cancer
• 1996-05-01 Plochl - Carnitine deficiency and carnitine therapy in patient with Rett syndrome
• 1996-01-01 Arens - Arousal and cardiorespiratory responses to hypoxia in PWS

1995

• 1995-12-01 Livingston - Hypercapnic arousal responses in PWS
• 1995-10-01 Morita - Studies of hypoxemic-reoxygenation injury - counteraction of oxidant damage by exogenous antioxidant coenzyme Q10
• 1995-06-01 Freezer - Obstructive sleep apnoea presenting as failure to thrive in infancy
• 1995-04-01 Cooper - Hormonal and metabolic profiles in obstructive sleep apnea syndrome and effects of CPAP treatment

1994

• 1994-11-01 Gozal - Absent peripheral chemosensitivity in PWS
• 1994-11-01 Arens - Hypoxic and hypercapnic ventilatory responses in PWS
• 1994-11-01 Antozzi - Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency
• 1994-06-01 Richards - Upper airway and sleep apnoea in PWS
• 1994-06-01 Clift - Sleep apnoea in PWS
• 1994-05-01 Sone - Muscle histochemistry in PWS
• 1994-03-01 Plioplys - L-carnitine as treatment of lethargy in children with chronic neurologic handicaps
• 1994-02-01 De Falco - Effect of the chronic treatment with L-acetylcarnitine in Downs syndrome
• 1994-01-03 Krsmanovic - Stimulation of gonadotropin-releasing hormone secretion by acetyl-L-carnitine in hypothalamic neurons and GT1 neuronal cells
• 1994-01-01 Taglialatela - Acetyl-L-carnitine increases nerve growth factor levels and choline acetyltransferase activity in CNS

Admin only: